Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Guohui Li being referenced
Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy
1995
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Guohui Li | 79 | 48 | 63 | 91 | 64 | 41 | 367 | |
| Ying Zheng | 25 | 16 | 69 | 28 | 14 | 35 | 368 | |
| Mansour Bahardoust | 57 | 55 | 53 | 12 | 34 | 58 | 391 | |
| José | 13 | 22 | 39 | 142 | 23 | 39 | 300 | |
| Ting Tian | 37 | 19 | 25 | 63 | 4 | 39 | 348 | |
| Laurie Erickson | 28 | 21 | 22 | 29 | 16 | 31 | 386 | |
| Leiming Xu | 18 | 26 | 47 | 11 | 21 | 24 | 372 | |
| Marijke A. de Vries | 21 | 30 | 77 | 11 | 30 | 26 | 411 | |
| R Dawar | 91 | 44 | 30 | 52 | 8 | 37 | 388 | |
| Feng Qin | 24 | 56 | 45 | 20 | 15 | 29 | 317 | |
| Julia Deutsch | 44 | 39 | 66 | 13 | 6 | 26 | 398 |
All Works
Login with ORCID to disown or claim papers
Loading papers...